VCU Massey researchers receive $18.1 million grant to lead a public health study on tobacco
VCU Massey Cancer Center researchers Thomas Eissenberg, Ph.D., and Robert Balster, Ph.D., have received an $18.1 million federal grant – VCU’s third largest to date – to study so-called modified risk tobacco products and other novel tobacco products, such as electronic cigarettes, and to develop an evaluation tool to help inform United States tobacco regulatory policy.
Making strides against breast cancer
In honor of Breast Cancer Awareness Month, find out the many ways VCU Massey Cancer Center is making strides in the prevention and treatment of breast cancer and ways in which you can celebrate and support these advances. A National Cancer Institute-designated cancer center, VCU Massey is helping to lead and shape the nation’s fight against breast and other cancers.
Prostate cancer screening: the ongoing debate
Since its adoption by the FDA in 1994, the prostate-specific antigen (PSA) test has reduced prostate cancer mortality rates by 39 percent. Despite the lives saved, whether or how the PSA test should be used for screening is at the center of an ongoing debate. Is the PSA test right for you? The answer to this question varies person to person, so I recommend that you talk to your doctor about your individual risk and educate yourself about the pros and cons of testing.
Communication in cancer care
Communication between cancer patients, caregivers, health care teams and researchers is critical to building trust, sharing information and making informed decisions. Laura A. Siminoff, Ph.D., Theresa A. Thomas Memorial Foundation Chair and associate director for cancer prevention and control at Virginia Commonwealth University Massey Cancer Center, was recently awarded two multi-million dollar grants to study how communication affects specific cancer outcomes.
VCU Massey introduces new, high-tech radiation technology to improve cancer care
VCU Massey Cancer Center has made a significant investment in improving the region’s cancer care by becoming the only cancer care provider in Richmond to utilize the TrueBeam™ linear accelerator. This advanced machine incorporates the latest image-guided radiation therapy technologies and higher dose rates to more accurately target patients’ tumors while sparing healthy tissue, reducing side effects and decreasing treatment times. The advanced capabilities of the TrueBeam™ system allow physicians to better treat complex cancers such as lung, liver, prostate and head and neck tumors that are close to vital organs and delicate tissue.